<DOC>
	<DOCNO>NCT02906501</DOCNO>
	<brief_summary>Introduction : The use low dose risperidone antipsychotic drug off-label augmentation treatment adolescent Attention Deficit Hyperactivity Disorder ( ADHD ) Disruptive Behavioral Disorder ( DBD ) become widely common worldwide , usually help control behavioral difficulty . While argue agent block dopaminergic receptor may deleterious cognitive effect , others stress moderate effect , possibly improve function domain , include cognitive function . Only study examine topic , inconclusive result . Aim study : To measure effect risperidone treatment various cognitive function population ADHD diagnose child adolescent normal IQ . Design : The study observational prospective open label clinical control trial . The investigator compare performance battery cognitive task use Penn Web-Based Computerized Neurocognitive Battery ( WebCNP ) IGT , child adolescent diagnose ADHD , without risperidone . Study population : Children adolescent diagnose ADHD , 8-17 year old , may eligible study . We recruit subject psychiatrist consider rispieridone treatment , already treat risperidone subject stimulant treatment . All pharmacological treatment supervise prescribed subject personal psychiatrist unrelated study . Significance : Better knowledge specific cognitive effect form therapy help u guide clinical decision , recommend monitoring daily clinical work .</brief_summary>
	<brief_title>Effect Risperidone Cognitive Functions Adolescents With ADHD Behavioral Disturbances</brief_title>
	<detailed_description>Study Purpose : To evaluate effect atypical antipsychotic augmentation , specifically risperidone specific cognitive domain adolescent ADHD behavioral disturbance . Hypotheses : 1 . Risperidone improve performance task assess attention , verbal memory , visual memory work memory adolescent ADHD DBDs 2 . Risperidone impair performance task assess spatial memory executive function adolescent ADHD DBDs . 3 . Risperidone , atypical antipsychotic , improve performance IGT . Study Design General : This study observational prospective open label clinical control trial . The plan study compare performance , without effect risperidone , various cognitive task child adolescent diagnose ADHD . Each subject perform battery cognitive task use Penn Web-Based Computerized Neurocognitive Battery ( WebCNP ) Iowa Gambling Test ( IGT ) . Experimental Procedure Each potential subject parent screen phone study . All enrolled subject instruct avoid take stimulant treatment day assessment session . On day enrolment , subject evaluate standard basic medical interview physical neurological examination evidence current neurological physical disorder . They also evaluate Development Well-Being Assessment ( DAWBA ) evidence psychiatric disorder . Parents also answer DAWBA questionnaire . Subjects qualify study parent receive comprehensive explanation study sign inform consent form . Subjects complete The Penn Web-Based Computerized Neurocognitive Battery ( WebCNP ) Iowa Gambling Test ( IGT ) . The first session take approximately 2.5 hour . All subject undergo follow session approximately month first session . The second session take approximately 2 hour . Subjects Groups II instruct start take risperidone first session day follow session . Subjects Group III instruct take risperidone atypical antipsychotic treatment day experiment night session least 8 hour session month . The treatment Risperidone give accord decision guidance subject 's physician . All subject invite perform Penn Continuous Performance Test third time , influence stimulant treatment . Normal IQ ascertain use Raven 's Progressive Matrices task part WebCNP battery .</detailed_description>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Male child adolescent diagnose ADHD Age : 817 year . Psychiatric comorbidities include : Major Depressive disorder , General Anxiety Disorder , Panic Disorder , Obsessive Compulsive Disorder , Oppositional Defiant Disorder , Conduct Disorder , Disruptive Dysregulation Mood Disorder , Intermittent Explosive Disorder phobia . Any current serious medical surgical illness . History major neurological illness ( include brain injury ) . Psychiatric comorbidities include : All psychotic disorder , Bipolar Disorder personality disorder . History alcohol substance abuse . Intellectual disability : Total IQ &lt; 70</criteria>
	<gender>Male</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Risperidone</keyword>
	<keyword>ADHD</keyword>
	<keyword>DBD</keyword>
	<keyword>IGT</keyword>
	<keyword>CNP</keyword>
	<keyword>Executive function</keyword>
</DOC>